clenbuterol has been researched along with Substance-Related Disorders in 8 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clenbuterol is a beta 2-agonist with anabolic properties that has not been seen previously with myocardial infarction." | 5.30 | Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms. ( Dobbs, T; Goldstein, DR; Krull, B; Plumb, VJ, 1998) |
| "Clenbuterol was identified in all the tissues, including femoral blood (1." | 1.51 | Complete Post-mortem Investigations in a Death Involving Clenbuterol After Long-term Abuse. ( Ameline, A; Comte, J; Dumestre-Toulet, V; Gheddar, L; Kintz, P; Raul, JS; Verschoore, M, 2019) |
| "Clenbuterol is a β2-adrenergic agonist with veterinary uses that has not been approved by the U." | 1.43 | A Case Series of Clenbuterol Toxicity Caused by Adulterated Heroin. ( Cumpston, KL; Emswiler, MP; Hieger, MA; Maskell, KF; Miller, KB; Sentz, JT; Wills, BK; Wolf, CE, 2016) |
| " After intensive questioning of the relatives a history of long-term use of anabolic steroids, clenbuterol as well as the intake of testosterone enanthate was conceded." | 1.38 | [Dialysis for severe rhabdomyolysis 7 days after multiple trauma]. ( Bone, HG; Freyhoff, J; Malin, A; Nobis, W, 2012) |
| "Clenbuterol is a long-acting B-2 agonist used in veterinary medicine." | 1.34 | Clenbuterol toxicity: an emerging epidemic. A case report and review. ( Bilkoo, P; Kagaoan, G; Riddle, CD; Thomas, J, 2007) |
| "Clenbuterol is a beta 2-agonist with anabolic properties that has not been seen previously with myocardial infarction." | 1.30 | Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms. ( Dobbs, T; Goldstein, DR; Krull, B; Plumb, VJ, 1998) |
| "-butyl-amino-ethanol hydrochloride (mabuterol) was tested in male rats dosed with 20, 100 and weekly increasing doses of 20, 40, 60, 80 and 100 mg/kg over 7 weeks." | 1.27 | Special toxicology--physical dependence potential, antigenicity and mutagenicity--of mabuterol. ( Amemiya, K; Arika, T; Asano, T; Kudoh, M; Nakamura, M, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kintz, P | 1 |
| Gheddar, L | 1 |
| Ameline, A | 1 |
| Dumestre-Toulet, V | 1 |
| Verschoore, M | 1 |
| Comte, J | 1 |
| Raul, JS | 1 |
| García-Esperón, C | 1 |
| Hervás-García, JV | 1 |
| Jiménez-González, M | 1 |
| Pérez de la Ossa-Herrero, N | 1 |
| Gomis-Cortina, M | 1 |
| Dorado-Bouix, L | 1 |
| López-Cancio Martinez, E | 1 |
| Castaño-Duque, CH | 1 |
| Millán-Torné, M | 1 |
| Dávalos, A | 1 |
| Hieger, MA | 1 |
| Emswiler, MP | 1 |
| Maskell, KF | 1 |
| Sentz, JT | 1 |
| Miller, KB | 1 |
| Wolf, CE | 1 |
| Cumpston, KL | 1 |
| Wills, BK | 1 |
| Malin, A | 1 |
| Freyhoff, J | 1 |
| Nobis, W | 1 |
| Bone, HG | 1 |
| Prezelj, A | 1 |
| Obreza, A | 1 |
| Pecar, S | 1 |
| Bilkoo, P | 1 |
| Thomas, J | 1 |
| Riddle, CD | 1 |
| Kagaoan, G | 1 |
| Amemiya, K | 1 |
| Asano, T | 1 |
| Arika, T | 1 |
| Nakamura, M | 1 |
| Kudoh, M | 1 |
| Goldstein, DR | 1 |
| Dobbs, T | 1 |
| Krull, B | 1 |
| Plumb, VJ | 1 |
2 reviews available for clenbuterol and Substance-Related Disorders
| Article | Year |
|---|---|
[Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature].
Topics: Adult; Alcoholism; Anabolic Agents; Brain Ischemia; Cerebral Angiography; Clenbuterol; Doping in Spo | 2013 |
Abuse of clenbuterol and its detection.
Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Humans; Substance Abuse Detection; Substance-Related | 2003 |
6 other studies available for clenbuterol and Substance-Related Disorders
| Article | Year |
|---|---|
Complete Post-mortem Investigations in a Death Involving Clenbuterol After Long-term Abuse.
Topics: Anabolic Agents; Autopsy; Clenbuterol; Fatal Outcome; Forensic Pathology; Forensic Toxicology; Human | 2019 |
A Case Series of Clenbuterol Toxicity Caused by Adulterated Heroin.
Topics: Adrenergic beta-Agonists; Adult; Clenbuterol; Drug Contamination; Heroin Dependence; Humans; Male; M | 2016 |
[Dialysis for severe rhabdomyolysis 7 days after multiple trauma].
Topics: Acute Kidney Injury; Adrenergic beta-Agonists; Adult; Amphetamine-Related Disorders; Anabolic Agents | 2012 |
Clenbuterol toxicity: an emerging epidemic. A case report and review.
Topics: Acute Disease; Clenbuterol; Drug Contamination; Emergency Service, Hospital; Heroin; Humans; Male; M | 2007 |
Special toxicology--physical dependence potential, antigenicity and mutagenicity--of mabuterol.
Topics: Adrenergic beta-Agonists; Animals; Bronchodilator Agents; Clenbuterol; DNA Repair; Ethanolamines; Gu | 1984 |
Clenbuterol and anabolic steroids: a previously unreported cause of myocardial infarction with normal coronary arteriograms.
Topics: Adrenergic beta-Agonists; Adult; Anabolic Agents; Clenbuterol; Coronary Angiography; Drug Synergism; | 1998 |